Fusion Pharmaceuticals Inc.

NASDAQ:FUSN

21.55 (USD) • At close June 3, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -94.897-87.612-81.047-78.333-16.189-11.652-6.264
Depreciation & Amortization 1.3450.9090.6340.4820.290.1140.023
Deferred Income Tax 0.845-3.162-0.991-0.576-0.059-0.0190.034
Stock Based Compensation 12.44410.8448.6033.3680.61800.112
Change In Working Capital -1.3173.66-14.5955.7363.085-0.5720.703
Accounts Receivables 0.0540.296-0.3570000
Inventory 00-12.0930000
Accounts Payables -0.7210.4-1.1832.5580.479-0.3810.589
Other Working Capital -0.652.964-0.9623.1782.606-0.1910.114
Other Non Cash Items -0.2222.08511.65639.556-1.4351.707-0.733
Operating Cash Flow -81.802-73.276-75.74-29.767-13.69-9.866-6.125
Investing Activities:
Investments In Property Plant And Equipment -3.89-2.142-1.491-1.123-0.456-1.123-0.096
Acquisitions Net 38.873-25.229-39.265-9.7000
Purchases Of Investments -230.57-165.156-172.469-219.03000
Sales Maturities Of Investments 191.697190.385211.7349.7000
Other Investing Activites -38.87325.22939.2659.7000
Investing Cash Flow -42.76323.08737.774-210.453-0.456-1.123-0.096
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 142.0065.8140.347197.625000
Common Stock Repurchased 01.2850-72.398000
Dividends Paid 0000000
Other Financing Activities -4.03168.3270.347212.67852.18718.36927.171
Financing Cash Flow 142.00640.7330.347265.50752.18718.36927.171
Other Information:
Effect Of Forex Changes On Cash 0.169000000
Net Change In Cash 17.61-9.456-37.61925.28738.0417.3820.95
Cash At End Of Period 61.92545.33354.78992.40867.12129.0821.7